QA: BeiGene Ltd. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001651308_2023_BeiGene_Ltd.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001651308, BeiGene Ltd.

  xvar xval
0 AssetsCurrent 5,207,078,000
1 IntangibleAssetsNetIncludingGoodwill 40,616,000
2 PropertyPlantAndEquipmentNet 845,946,000
3 remainder_Assets 285,650,000
4 LiabilitiesCurrent 1,468,528,000
5 LiabilitiesNoncurrent 527,407,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 286,475,000
8 SellingGeneralAndAdministrativeExpense 1,277,852,000
9 ResearchAndDevelopmentExpense 1,640,508,000
10 remainder_Expenses 43,529,000
11 remainder_Revenues 1,415,921,000
12 remainder_NetIncome -171,372,000
13 remainder_ComprehensiveNetIncome -95,367,000
  yvar yval
0 Assets 6,379,290,000
1 Liabilities 1,995,935,000
2 Expenses 3,248,364,000
3 Revenues 1,415,921,000
4 StockholdersEquity 4,383,355,000
5 NetIncome -2,003,815,000
6 ComprehensiveNetIncome -2,051,498,500
7 BaseVar 6,653,124,500
8 EconomicCapitalRatio 1.31

Edgar->Model Mapping

Feature Distribution

Change over Time